Sign In
Buy INCY
$119.80
-0.800 (-0.663%)
At Close: Aug 05, 2026
Entropy Technologies LP Grows Stock Holdings in Incyte Corporation $INCY
04:37am, Monday, 27'th Jul 2026
Entropy Technologies LP increased its position in Incyte Corporation (NASDAQ: INCY) by 29.6% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 26,077 share
Dai ichi Life Insurance Company Ltd Boosts Stake in Incyte Corporation $INCY
03:56am, Monday, 27'th Jul 2026
Dai ichi Life Insurance Company Ltd boosted its holdings in Incyte Corporation (NASDAQ: INCY) by 60.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchang
Incyte Gears Up to Report Q2 Earnings: Is a Beat Around the Corner?
11:41am, Friday, 24'th Jul 2026
INCY heads into Q2 earnings with strong Jakafi demand, Opzelura momentum and rising royalties, fueling expectations for an earnings beat.
HALO Inks Deal With INCY to Support Cancer Therapy Development
11:40am, Tuesday, 21'st Jul 2026
Halozyme grants ENHANZE rights to Incyte for developing subcutaneous cancer therapy formulations, aiming to improve treatment convenience for patients.
Incyte (INCY) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Tuesday, 21'st Jul 2026
Incyte (INCY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bank of New York Mellon Corp Trims Stock Position in Incyte Corporation $INCY
05:54am, Tuesday, 21'st Jul 2026
Bank of New York Mellon Corp lessened its holdings in Incyte Corporation (NASDAQ: INCY) by 1.3% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commi
Fifth Third Bancorp Boosts Stock Position in Incyte Corporation $INCY
04:05am, Tuesday, 21'st Jul 2026
Fifth Third Bancorp boosted its stake in shares of Incyte Corporation (NASDAQ: INCY) by 145.2% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The firm o
Andra AP fonden Has $24.38 Million Holdings in Incyte Corporation $INCY
03:19am, Tuesday, 21'st Jul 2026
Andra AP fonden lessened its position in Incyte Corporation (NASDAQ: INCY) by 34.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
Agreement provides Incyte the rights to develop and commercialize ENHANZE® with its mutCALR development program and an option to nominate up to two additional targets SAN DIEGO, July 20, 2026 /PRNews
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte Data to Be Highlighted in Four Rapid Oral Presentations at ESMO 2026 Support Efforts to Improve Outcomes in Difficult-to-Treat Cancers.
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Phase 1/2 Multidose Data for VGA039 (Latarcibart) Show Substantial Bleed Reductions in Patients with all Von Willebrand Disease Types.
2 Fast-Growing Pharmaceutical Stocks to Buy Now
08:05pm, Wednesday, 08'th Jul 2026
Incyte and TG Therapeutics are seeing strong share growth, backed up by booming revenue and earnings.
Incyte to Report Second Quarter Financial Results
08:00am, Wednesday, 08'th Jul 2026
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its second quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July 28, 202
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio.
Incyte Shares Rise on EPS Growth, Lifted Guidance, Expansion
11:58am, Friday, 03'rd Jul 2026
Three outlier inflow signals push biopharmaceutical firm Incyte Corporation (INCY) up 71% in a year.
